After re-stimulation of blood lymphocytes ex vivo with melanoma Trp2 or OVA peptides, significant CD8 T-cell responses against both antigens could be detected, and the responses were not dependent on CD4 T-cell help (Figure 4A). This evidence concerns the gene CD8A and melanoma.